{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:16:00Z","timestamp":1772576160246,"version":"3.50.1"},"reference-count":33,"publisher":"Cambridge University Press (CUP)","issue":"9","license":[{"start":{"date-parts":[[2007,6,29]],"date-time":"2007-06-29T00:00:00Z","timestamp":1183075200000},"content-version":"unspecified","delay-in-days":3223,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0022215100141878_sec01\"><jats:title>Objective<\/jats:title><jats:p>To evaluate the efficacy of the angiogenesis inhibitor AGM-1470 for the experimental treatment of nasopharyngeal carcinoma (NPC).<\/jats:p><\/jats:sec><jats:sec id=\"S0022215100141878_sec02\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>A NPC human tumour model was built by tumour-bearing nude mice using the NPC cell line CNE-2. Twenty-one BALB\/c nude mice bearing CNE-2 xenografts were randomized into a treatment group and a control group. In the treatment group, AGM-1470 was injected 30 mg\/kg subcutaneously every other day; while the vehicle (three per cent ethanol solution in 0.9 per cent saline) was given to the mice in control group. Tumour volumes and animal weights were measured every third day. Autopsy was performed after 18 days of treatment. The tumour tissue as well as the murine tissues of heart, kidney, and liver in each mouse were removed for formalin fixation and routine HE staining. Pathological evaluation was performed in these tissues.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215100141878_sec03\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>There was a significant difference in tumour volume between the two groups at day 9 of treatment and this increased thereafter. At day 15 of treatment, the tumour volume was 4251 \u00b1 559 mm<jats:sup>3<\/jats:sup> (<jats:italic>n<\/jats:italic> = 10) in the control group versus 3122 \u00b1 967 mm<jats:sup>3<\/jats:sup> (<jats:italic>n<\/jats:italic> = 11) in the AGM-1470 treated group (<jats:italic>p<\/jats:italic> = 0.004); and T:C ratio (mean tumour volume of treated\/mean tumour volume of control) was 0.73, resulting in a 27 per cent decrease in tumour growth. Central necrosis and consequential shrinkage of tumours occurred in both groups at the end of experiment. Physical toxicity and histological toxicity of heart, liver, and kidney did not result from AGM-1470 therapy.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215100141878_sec04\" sec-type=\"conclusion\"><jats:title>Conclusions<\/jats:title><jats:p>AGM-1470 suppresses the growth of the human NPC cell line CNE-2. Treatment by AGM-1470 has no physical nor histological toxicity. Angiogenesis inhibitors may be effective in the treatment of the local lesion of NPC.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0022215100141878","type":"journal-article","created":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T10:12:31Z","timestamp":1196417551000},"page":"849-853","source":"Crossref","is-referenced-by-count":16,"title":["Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470)"],"prefix":"10.1017","volume":"112","author":[{"given":"Chao-nan","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Qing","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-liang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Huang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2007,6,29]]},"reference":[{"key":"S0022215100141878_ref013","doi-asserted-by":"publisher","DOI":"10.1038\/348555a0"},{"key":"S0022215100141878_ref008","first-page":"382","article-title":"Nasopharyngeal cancer: epidemiology, staging and treatment","volume":"21","author":"Fandi","year":"1994","journal-title":"Seminars in Oncology"},{"key":"S0022215100141878_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)02126-V"},{"key":"S0022215100141878_ref010","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199607)179:3<232::AID-PATH505>3.0.CO;2-A"},{"key":"S0022215100141878_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(96)00388-7"},{"key":"S0022215100141878_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66196-2"},{"key":"S0022215100141878_ref002","first-page":"2073","article-title":"AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle","volume":"54","author":"Antoine","year":"1994","journal-title":"Cancer Research"},{"key":"S0022215100141878_ref015","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(91)91529-L"},{"key":"S0022215100141878_ref029","first-page":"5233","article-title":"Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumour growth of hormone-independent human breast and prostate carcinoma cell lines","volume":"53","author":"Yamaoka","year":"1993","journal-title":"Cancer Research"},{"key":"S0022215100141878_ref009","first-page":"1182","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1972","journal-title":"New England and Journal of Medicine"},{"key":"S0022215100141878_ref028","first-page":"1","article-title":"Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470)","volume":"14","author":"Yamamoto","year":"1994","journal-title":"Anticancer Research"},{"key":"S0022215100141878_ref032","doi-asserted-by":"publisher","DOI":"10.1007\/BF01058456"},{"key":"S0022215100141878_ref022","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1419::AID-CNCR1>3.0.CO;2-7"},{"key":"S0022215100141878_ref033","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.2910310509","article-title":"Cytogenetic study on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma","volume":"31","author":"Zhang","year":"1983","journal-title":"International Journal of Cancer"},{"key":"S0022215100141878_ref014","first-page":"5143","article-title":"Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice","volume":"54","author":"Kato","year":"1994","journal-title":"Cancer Research"},{"key":"S0022215100141878_ref012","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.149.1.6412281"},{"key":"S0022215100141878_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)90306-9"},{"key":"S0022215100141878_ref018","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90740-9"},{"key":"S0022215100141878_ref019","first-page":"12","volume-title":"Clinic of NPC and experimental research","author":"Li","year":"1983"},{"key":"S0022215100141878_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(93)90246-H"},{"key":"S0022215100141878_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(95)90583-9"},{"key":"S0022215100141878_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(94)90020-5"},{"key":"S0022215100141878_ref021","unstructured":"Qian C. N. , Min H. Q. , Liang X. M. , Zheng S. S. , Lin H. L. (1998) Primary study of neovasculature correlating with metastatic nasopharyngeal carcinoma using computer image analysis (in press)."},{"key":"S0022215100141878_ref024","first-page":"836","article-title":"Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470","volume":"55","author":"Tanaka","year":"1995","journal-title":"Cancer Research"},{"key":"S0022215100141878_ref026","first-page":"237","article-title":"Antiangiogenic treatment (TNP-470\/minocyclin) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma","volume":"7","author":"Teicher","year":"1995","journal-title":"Oncology Research"},{"key":"S0022215100141878_ref025","first-page":"73","article-title":"Microvessel density of tumor is a prognostic factor of malignancies","volume":"10","author":"Tao","year":"1996","journal-title":"Journal of Practical Oncology (China)"},{"key":"S0022215100141878_ref027","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199609000-00001"},{"key":"S0022215100141878_ref030","first-page":"2566","article-title":"Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo","volume":"53","author":"Yanase","year":"1993","journal-title":"Cancer Research"},{"key":"S0022215100141878_ref031","first-page":"1355","article-title":"Enhancement effect of an anti-angiogenic agent, TNP-470 on hyperthermia-induced growth suppression of human esophageal and gastric cancers transplantable to nude mice","volume":"15","author":"Yano","year":"1995","journal-title":"Anticancer Research"},{"key":"S0022215100141878_ref006","first-page":"283","article-title":"Neoadjuvant chemotherapy (NACY) with Epirubicin (EPI), Cisplatin (CDDP), Bleomycin (BLEO) (BEC) in undifferentiated nasopharyngeal cancer (UNCT): Preliminary results of an international Phase III Trial","volume":"13","author":"Cvitkovic","year":"1994","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"S0022215100141878_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92166-Y"},{"key":"S0022215100141878_ref004","first-page":"439","article-title":"Suppression of tumor metastasis by angiogenesis inhibition","volume":"42","author":"Brem","year":"1991","journal-title":"Surgical Forum"},{"key":"S0022215100141878_ref016","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.41"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215100141878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T20:22:13Z","timestamp":1557519733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215100141878\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["S0022215100141878"],"URL":"https:\/\/doi.org\/10.1017\/s0022215100141878","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}